{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:16:27Z","timestamp":1788300987014,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.nbd.2026.107570","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:38:04Z","timestamp":1786322284000},"page":"107570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's disease"],"prefix":"10.1016","volume":"228","author":[{"given":"Maximilian","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dzamko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.nbd.2026.107570_bb0005","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/WNL.56.6.730","article-title":"Risk of dementia in Parkinson\u2019s disease: a community-based, prospective study","volume":"56","author":"Aarsland","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0010","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41420-023-01734-1","article-title":"IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson\u2019s disease models","volume":"9","author":"Arcos","year":"2023","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147319","article-title":"An Alzheimer\u2019s disease-derived biomarker signature identifies Parkinson\u2019s disease patients with dementia","volume":"11","author":"Berlyand","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0025","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13195-023-01288-5","article-title":"Circulating insulin-like growth factor-1 and brain health: evidence from 369,711 participants in the UK biobank","volume":"15","author":"Cao","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"11","key":"10.1016\/j.nbd.2026.107570_bb0035","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/cns.13708","article-title":"Platelet-derived growth factor (PDGF)-BB protects dopaminergic neurons via activation of Akt\/ERK\/CREB pathways to upregulate tyrosine hydroxylase","volume":"27","author":"Chen","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2026.107570_bb0040","article-title":"Predictors of cognitive impairment in newly diagnosed Parkinson\u2019s disease with normal cognition at baseline: a 5-year cohort study","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2026.107570_bb0045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"23","author":"Collaborators","year":"2024","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.nbd.2026.107570_bb0050","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Movement dis."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13195-025-01791-x","article-title":"Low-dose interleukin-2 in patients with mild to moderate Alzheimer\u2019s disease: a randomized clinical trial","volume":"17","author":"Faridar","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"12","key":"10.1016\/j.nbd.2026.107570_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.nbd.2026.107570_bb0065","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/psyg.13122","article-title":"Association of lipid levels with motor and cognitive function and decline in Parkinson\u2019s disease","volume":"24","author":"Gu","year":"2024","journal-title":"Psychogeriatrics"},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41531-022-00409-5","article-title":"Machine learning-based prediction of cognitive outcomes in de novo Parkinson\u2019s disease","volume":"8","author":"Harvey","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.nbd.2026.107570_bb0075","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbi.2024.05.013","article-title":"IGF-1 gene therapy prevents spatial memory deficits and modulates dopaminergic neurodegeneration and inflammation in a parkinsonism model","volume":"119","author":"Herrera","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41531-025-00958-5","article-title":"Four questions to predict cognitive decline in de novo Parkinson\u2019s disease","volume":"11","author":"Hlavnicka","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41531-023-00461-9","article-title":"A proteogenomic view of Parkinson\u2019s disease causality and heterogeneity","volume":"9","author":"Kaiser","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"10.1016\/j.nbd.2026.107570_bb0090","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3233\/JPD-230007","article-title":"Serum uric acid as a putative biomarker in prodromal Parkinson\u2019s disease: longitudinal data from the PPMI study","volume":"13","author":"Koros","year":"2023","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.nbd.2026.107570_bb0095","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/brain\/awad322","article-title":"Neuroinflammation is linked to dementia risk in Parkinson\u2019s disease","volume":"147","author":"Kouli","year":"2024","journal-title":"Brain J. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2026.107570_bb0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11065-015-9307-8","article-title":"Do CSF biomarkers predict progression to cognitive impairment in Parkinson\u2019s disease patients? A systematic review","volume":"25","author":"Leaver","year":"2015","journal-title":"Neuropsychol. Rev."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41531-023-00476-2","article-title":"Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD","volume":"9","author":"Lerche","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.nbd.2026.107570_bb0110","article-title":"Insights into the role of platelet-derived growth factors: implications for Parkinson\u2019s disease pathogenesis and treatment","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2026.107570_bb0115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.nbd.2026.107570_bb0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Movement dis."},{"issue":"8","key":"10.1016\/j.nbd.2026.107570_bb0125","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S1474-4422(17)30122-9","article-title":"Prediction of cognition in Parkinson\u2019s disease with a clinical-genetic score: a longitudinal analysis of nine cohorts","volume":"16","author":"Liu","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107570_bb0130","series-title":"A unified approach to interpreting model predictions","first-page":"4768","author":"Lundberg","year":"2017"},{"key":"10.1016\/j.nbd.2026.107570_bb0135","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbi.2020.07.005","article-title":"Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson\u2019s disease","volume":"89","author":"Magistrelli","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-025-00827-y","article-title":"Immune cell metabolic dysfunction in Parkinson\u2019s disease","volume":"20","author":"Mark","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107570_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102095","article-title":"Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson\u2019s disease","volume":"46","author":"Martin-Montanez","year":"2021","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-023-00468-2","article-title":"LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts","volume":"9","author":"Merchant","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.nbd.2026.107570_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073094","article-title":"Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson\u2019s disease and associated with cognitive impairment: a pilot study","volume":"8","author":"Mielke","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.nbd.2026.107570_bb0160","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","article-title":"Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls","volume":"89","author":"Mollenhauer","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107570_bb0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nbd.2016.06.002","article-title":"Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson\u2019s disease","volume":"94","author":"Padel","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107570_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.853372","article-title":"Microvascular changes in Parkinson\u2019s disease- focus on the neurovascular unit","volume":"14","author":"Paul","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010286","article-title":"Head-to-head comparison of aptamer- and antibody-based proteomic platforms in human cerebrospinal fluid samples from a real-world memory clinic cohort","volume":"26","author":"Puerta","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.nbd.2026.107570_bb0180","first-page":"3361","article-title":"Immunometabolism in brain aging and neurodegeneration: bridging metabolic pathways and immune responses","volume":"16","author":"Rahimpour","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.nbd.2026.107570_bb0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of Interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00401-024-02706-0","article-title":"Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson\u2019s disease","volume":"147","author":"Rutledge","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107570_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.parkreldis.2020.04.009","article-title":"Serum neurofilament light chain levels reflect cortical neurodegeneration in de novo Parkinson\u2019s disease","volume":"74","author":"Sampedro","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","article-title":"Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study","volume":"16","author":"Schrag","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107570_bb0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbi.2025.05.020","article-title":"Multimodal markers of immune activation predict cognitive outcomes in Parkinson\u2019s disease","volume":"129","author":"Scott","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.nbd.2026.107570_bb0210","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JPD-202097","article-title":"Cognitive function and quality of life in Parkinson\u2019s disease: a cross-sectional study","volume":"10","author":"Tang","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"14","key":"10.1016\/j.nbd.2026.107570_bb0215","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1212\/WNL.0000000000207725","article-title":"High-throughput CSF proteomics and machine learning to identify proteomic signatures for Parkinson disease development and progression","volume":"101","author":"Tsukita","year":"2023","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nbd.2026.107570_bb0220","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/sim.4780120902","article-title":"Confidence intervals for a binomial proportion","volume":"12","author":"Vollset","year":"1993","journal-title":"Stat. Med."},{"issue":"8","key":"10.1016\/j.nbd.2026.107570_bb0225","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/mds.23661","article-title":"The economic impact of cognitive impairment in Parkinson\u2019s disease","volume":"26","author":"Vossius","year":"2011","journal-title":"Movement dis."},{"key":"10.1016\/j.nbd.2026.107570_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1289934","article-title":"Abnormalities of cerebral blood flow and the regional brain function in Parkinson\u2019s disease: a systematic review and multimodal neuroimaging meta-analysis","volume":"14","author":"Xie","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00702-023-02704-8","article-title":"The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson\u2019s disease","volume":"131","author":"Zhao","year":"2024","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0240","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.nbd.2026.107570_bb0245","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41531-024-00828-6","article-title":"Multimodal neuroimaging-based prediction of Parkinson\u2019s disease with mild cognitive impairment using machine learning technique","volume":"10","author":"Zhu","year":"2024","journal-title":"NPJ Parkinsons Dis"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126003153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126003153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:00:06Z","timestamp":1788300006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126003153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":49,"alternative-id":["S0969996126003153"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107570","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin like growth factor and cytokine signalling predict future cognitive impairment in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107570"}}